Bank of America
EVH icon

Bank of America’s Evolent Health EVH Stock Holding History

Bank of America’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-160,000
Closed -$1.27M – 7314
2019
Q2 		$1.27M Buy
+160,000
New +$1.89M ﹤0.01% 4401

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America's EVH Position: Q1 2026 in Review

Bank of America reduced its Evolent Health (EVH) stake by 50% in Q1 2026, selling an estimated $889K and leaving 280,854 shares worth $640K. The position accounts for ﹤0.01% of the portfolio, ranked #4763.

Bank of America first reported a position in EVH in Q3 2015 and has held it in 43 quarters since. The position peaked at $15.9M in Q1 2023. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Bank of America held 280,854 shares of Evolent Health worth $640K as of Q1 2026.
  • Bank of America sold 280,096 Evolent Health shares in Q1 2026, an estimated $889K.
  • Evolent Health made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4763 holding.
  • Bank of America first reported a position in Evolent Health in Q3 2015 and has held it in 43 quarters since.
  • Bank of America's Evolent Health position peaked at $15.9M in Q1 2023.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.